| Symbol | ANABV |
|---|---|
| Name | ANAPTYSBIO, INC |
| Sector | HEALTH CARE |
| Region | UNDEFINED |
| Industry | Pharmaceutical Preparations |
| Address | 10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA 92121 |
| Telephone | 858-362-6295 |
| Fax | — |
| — | |
| Website | https://www.anaptysbio.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | — |
| Description | AnaptysBio Inc is clinical-stage biotechnology company. It is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company develops product candidates to address emerging biological targets using its proprietary, antibody discovery technology platform, which is designed to replicate, in vitro, the natural process of antibody generation. Its product candidates are ANB020, ANB019, and Checkpoint receptor agonist. The entity generates revenue from the collaborative research and development arrangements. Additional info from NASDAQ: |
Delaware Chancery Court Rules in Favor of Anaptys by Dismissing Tesaro’s Anticipatory Breach Claim
Read moreNew Form 8-K/A - ANAPTYSBIO, INC <b>Filed:</b> 2026-04-24 <b>AccNo:</b> 0001193125-26-177317 <b>Size:</b> 303 KB <br />Item 9.01: Financial Statements and Exhibits
Read moreNew Form 4/A - ANAPTYSBIO, INC <b>Filed:</b> 2026-04-23 <b>AccNo:</b> 0001673528-26-000012 <b>Size:</b> 5 KB
Read moreSchmid John P. 🟡 adjusted position in 0 shares (20 derivative) of ANAPTYSBIO, INC (ANAB) at $104.81 ($5.7M) Transaction Date: Apr 20, 2026 | Filing ID: 000006
Read moreRENTON HOLLINGS 🟡 adjusted position in 0 shares (20 derivative) of ANAPTYSBIO, INC (ANAB) at $104.81 ($5.7M) Transaction Date: Apr 20, 2026 | Filing ID: 000002
Read moreFaga Daniel 🟡 adjusted position in 5.5K shares (14 derivative) of ANAPTYSBIO, INC (ANAB) at $43.91 ($41.2M) Transaction Date: Apr 20, 2026 | Filing ID: 000011
Read moreAnaptys Completes Separation of First Tracks Biotherapeutics and Now Exclusively Manages GSK and Vanda Financial Collaborations
Read moreAnaptysBio, Inc. - Common Stock When Issued (ANABV) was added to the exchange traded list on NASDAQ
Read moreNew Form 3 - ANAPTYSBIO, INC <b>Filed:</b> 2026-04-03 <b>AccNo:</b> 0001833453-26-000002 <b>Size:</b> 8 KB
Read more